Energy Transfer LP heads into its May 6 Q1 results with the units up sharply and the Street broadly onside — but the debate over distribution sustainability and capex discipline looms large.
Options positioning signals genuine optimism, not just relief. The put/call ratio has dropped to 0.16, sitting near the bottom of its 52-week range (annual low: 0.14) and about one standard deviation below its 20-day average of 0.17. Call demand is running well ahead of put demand — a posture that reflects more confidence than caution into the release. The unit price has climbed 7.7% over the past month to $20.39, and 5% on the week alone, extending the partnership's recovery from the tariff-driven selloff in early April.
Short interest is not the story here. At just 0.84% of the free float — and down roughly 7% from a month ago — there is almost no bearish conviction in the lending market. Borrow availability is effectively unlimited for a name this size. The cost to borrow has spiked to 6.2% this week, roughly four times its level a week ago, but this appears to reflect episodic volatility rather than a structural squeeze signal; the absolute level remains low and the 52-week peak on availability utilization is only 3.5%. Short sellers are not leaning in.
Bulls point to the pipeline of volumes growth — gathering throughput up roughly 25% since 2022 — and the strategic reach of assets including Sunoco and USA Compression. Forward EPS growth ranks in the 77th percentile across the universe, the dividend score is in the 89th percentile, and analyst consensus is firmly Buy, with Wells Fargo lifting its target to $25 in March and Truist initiating at Buy with a $23 target the same month. The mean price target of $22.59 implies roughly 11% upside from current levels. Bears, however, flag the capex burden — Q2 free cash flow turned negative in recent quarters — and the partnership's large debt load against an EV/EBITDA multiple of 8.7x that leaves limited margin for error on distribution coverage. Morgan Stanley's equal-weight stance at $21 reflects that ceiling concern: plenty of yield, less certain total return.
Founder and Executive Chairman Kelcy Warren made his position clear last autumn. He bought 2 million units across two sessions in November 2025 at around $16.80–$16.95, and added another 2 million units the prior August near $17.30 — over $68 million in combined purchases. Warren already holds nearly 9% of units outstanding, and his continued buying at those levels has proven well-timed given the current price above $20. The CFO and both Co-CEOs sold units in December at $16.60 — routine post-vesting disposals rather than a directional signal, given their small scale relative to Warren's open-market accumulation.
The Q1 print will test whether volume growth and distributable cash flow are tracking the kind of trajectory that supports a further re-rating — or whether the bears' free cash flow and margin concerns are starting to land in the actual numbers.
See the live data behind this article on ORTEX.
Open ET on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
